Osterlund, P.; Kinos, S.; Pfeiffer, P.; Salminen, T.; Kwakman, J.J.M.; Frödin, J.-E.; Shah, C.H.; Sorbye, Halfdan; Ristamäki, R.; Halonen, P.; Soveri, L.M.; Heervä, E.; Ålgars, A.; Bärlund, M.; Hagman, H.; McDermott, R.; O'Reilly, M.; Röckert, R.; Liposits, G.; Kallio, R.; Flygare, P.; Teske, A.J.; van Werkhoven, Werkhoven; Punt, C.J.A.; Glimelius, B. (Journal article; Peer reviewed, 2022)
Background
Capecitabine- or 5-fluorouracil (5-FU)-based chemotherapy is widely used in many solid tumours, but is associated with cardiotoxicity. S-1 is a fluoropyrimidine with low rates of cardiotoxicity, but evidence ...